IMAB – i-mab - american depositary shares (US:NASDAQ)
Stock Stats
News
I-Mab to Participate at the Piper Sandler Healthcare Conference
I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
I-Mab Reports Third Quarter 2024 Results [Yahoo! Finance]
I-Mab Reports Third Quarter 2024 Results
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
Form 6-K I-Mab For: Nov 14
Form 6-K I-Mab For: Nov 06
Form 6-K I-Mab For: Nov 05
Form 6-K I-Mab For: Oct 24
Form 6-K I-Mab For: Sep 23
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.